The Value of Artificial Intelligence in Laboratory Medicine

Abstract

Objectives As laboratory medicine continues to undergo digitalization and automation, clinical laboratorians will likely be confronted with the challenges associated with artificial intelligence (AI). Understanding what AI is good for, how to evaluate it, what are its limitations, and how it can be implemented are not well understood. With a survey, we aimed to evaluate the thoughts of stakeholders in laboratory medicine on the value of AI in the diagnostics space and identify anticipated challenges and solutions to introducing AI. Methods We conducted a web-based survey on the use of AI with participants from Roche’s Strategic Advisory Network that included key stakeholders in laboratory medicine. Results In total, 128 of 302 stakeholders responded to the survey. Most of the participants were medical practitioners (26%) or laboratory managers (22%). AI is currently used in the organizations of 15.6%, while 66.4% felt they might use it in the future. Most had an unsure attitude on what they would need to adopt AI in the diagnostics space. High investment costs, lack of proven clinical benefits, number of decision makers, and privacy concerns were identified as barriers to adoption. Education in the value of AI, streamlined implementation and integration into existing workflows, and research to prove clinical utility were identified as solutions needed to mainstream AI in laboratory medicine. Conclusions This survey demonstrates that specific knowledge of AI in the medical community is poor and that AI education is much needed. One strategy could be to implement new AI tools alongside existing tools.

Machine Learning as a Novel Method to Support Therapeutic Drug Management and Precision Dosing

“…Also in laboratory medicine, artificial intelligence and machine learning are finding their application. 3 To date, population pharmacokinetic (popPK) models have been used to describe drug exposure over time in patients. With popPK models it is also possible to identify sources of between-patient variability in drug exposure such as body weight and renal function.…”

“…By mining the complex and heterogeneous data from electronic health records (referred to as “big data”), patients can benefit from previous collective experience leading to improvements in diagnostic procedures, outcome predictions, and individualized treatments. Also in laboratory medicine, artificial intelligence and machine learning are finding their application 3 …”

Barriers of artificial intelligence implementation in the diagnosis of obstructive sleep apnea

“…While the logic AI offers is superior and demonstrates high accuracy, human intuition is not replaceable but can collaborate with the logical advances AI offers [ 61 ]. Of the stakeholders surveyed, in an analysis of the value of AI in laboratory medicine, a substantial proportion of those who reported AI as valuable were unsure of reasons supporting this stance and 19% did not perceive the adoption of AI to be valuable in their organization [ 62 ]. This highlights how education regarding AI and evidence based studies displaying it’s efficiency and value on a practical level are critical for shifting the paradigm regarding this emerging technology.…”

“…In a study evaluating the value of AI in laboratory medicine, stakeholders were surveyed about what they felt was needed in order for AI to be adopted for diagnostic use [ 62 ]. While most participants responded unsure of what was needed, others highlighted the need for education.…”

“…While most participants responded unsure of what was needed, others highlighted the need for education. Specific training to the devices, AI courses and different support systems were suggested to help the adoption of AI into clinical practice [ 62 ]. The uncertainty reflected in the survey demonstrated the need for AI education and the development of an educational program which collaborates with stakeholders.…”